Hypertrophic cardiomyopathy (HCM) is a monogenic cardiovascular disorder that is caused mainly by mutations in sarcomeric contractile proteins such as cardiac troponin T (TNNT2). Becker et al. create a tnnt2 zebrafish morphant to study basic mechanisms of HCM pathology and to identify modifiers of the HCM phenotype. Their findings indicate that tnnt2 deficiency initiates cardiac defects at early developmental stages, including abnormalities in cardiomyocyte calcium handling. These findings suggest that the pathology of HCM might arise during development, before the onset of symptoms.
- Written by editorial staff. © 2011. Published by The Company of Biologists Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.